 It
is estimated that one-third of the U.S. population
suffers from sleep disorders. Approximately 40 million
individuals are chronic sufferers, yet less than
10% have been diagnosed or sought treatment.
Regardless of the type of sleep disorder, the
impact on individuals is considerable. Clinically,
people suffering from sleep disorders have an
increased likelihood of cardiovascular disease,
hypertension and mortality. At the same time,
these individuals experience reduced cognitive
performance that lowers job performance, decreases
their quality of life and makes them ten times
more likely to be in an automobile accident. These
individuals are more susceptible to work-related
injuries, depression and family discord, too.
Economically, sleep disorders in the U.S. are
estimated to cost $60 - $115 billion annually
for medical and indirect expenses. Sleep studies
and therapies alone cost an estimated $5 billion
per year. Individuals with undiagnosed sleep disorders
have also been documented as heavy users of medical
services.
Seven types of sleep disorders occur most frequently
in the U.S. We have many treatments that can improve
the symptoms of those disorders but they may be
permanent problems. The disorders that you are
looking at are conditions where a nerve may have
an irreversible injury peripherally or in the
CNS (brain) or the last one in the bone. We use
low level or cold laser treatments in combination
with medications and our appliance therapy to
reduce symptoms and improve quality of life. The
combination of treatment in this way usually reduces
or sometimes eliminates the dosage of medications
and therefore the side effects (drowsiness, fatigue,
constipation, dizziness, etc), which in itself
improves quality of life.
- Sleep Apnea Syndrome, affecting an
estimated 20 million individuals
- Chronic/Severe Insomnia, affecting
an estimated 20 million individuals
- Circadian Rhythm Disorder, affecting
an estimated 17 million individuals
- RLS/PLMD: Restless Leg Syndrome / Periodic
Limb Movement Disorder, affecting an estimated
10 million individuals
- Parasomnia, affecting an estimated
3 million individuals
- Cheyne-Stokes, affecting an estimated
1.5 million individuals
- Narcolepsy, affecting an estimated
300,000 individuals
Learn more about Sleep
Apnea
Learn about Diagnosis and
Treatment of Sleep Apnea
Back to Top
|
